Abstract
Magnetic resonance (MR) is one of the most widely used imaging modalities in contemporary medicine to obtain images of pathological areas. Still, there is a big effort to facilitate the accumulation of contrast in the required zone and further increase a local spatial concentration of a contrast agent for better imaging. Certain particulate carriers able to carry multiple contrast moieties can be used for an efficient delivery of contrast agents to areas of interest and enhancing a signal from these areas. Among those carriers, liposomes draw special attention because of their easily controlled properties and good pharmacological characteristics. To enhance the signal intensity from a given reporter metal in liposomes, one may attempt to increase the net quantity of carrier-associated reporter metal by using polylysine (PLL)-based polychelating amphiphilic polymers (PAP). In addition to heavy load of reporter metal onto the pharmaceutical nanocarrier (liposome), the accumulation of the contrast nanoparticles in organs and tissues of interest (such as tumors) can be significantly enhanced by targeting such particles both “passively,” via the so-called enhanced permeability and retention (EPR) effect, or “actively,” using various target-specific ligands, such as monoclonal antibodies. Combining three different properties – heavy load with Gd via the liposome membrane-incorporated PAP and tumor specificity mediated by the liposome-attached mAb 2C5 – in a single nanoparticle of long-circulating (PEGylated) liposomes could provide a new contrast agent for highly specific and efficient tumor MRI.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wolf GL (1999) Delivery of diagnostic agents: achievements and challenges. Adv Drug Deliv Rev 37(1–3):1–12
Gregoriadis G (1993) Liposome technology, vol 1–3. CRC Press, Boca Raton, FL
Lasic DD (1993) Liposomes from physics to applications. Elsevier Science Publishers, Amsterdam
Torchilin VP (1997) Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging. Q J Nucl Med 41:141–153
Tóth É, Helm L (2002) Relaxivity of MRI contrast agents. In: Krause W (ed) Topics in current chemistry, contrast agent 1, vol 221. Springer-Verlag, Berlin Heidelberg, pp 61–63
Unger E, Shen DK, Wu GL, Fritz T (1991) Liposomes as MR contrast agents: pros and cons. Magn Reson Med 22(2):304–308
Barsky D, Pütz B, Schulten K, Magin RL (1992) Theory of paramagnetic contrast agents in liposome systems. Magn Reson Med 24(1):1–13
Unger E, Tilcock C, Ahkong QF, Fritz T (1990) Paramagnetic liposomes as magnetic resonance contrast agents. Invest Radiol 25(Suppl 1):S65–S66
Gries H (2002) Extracellular MRI contrast agents based on gadolinium. In: Krause W (ed) Topics in current chemistry, contrast agent 1, vol 221. Springer-Verlag, Berlin Heidelberg, pp 3–29
Strijkers GJ, Mulder WJ, van Heeswijk RB, Frederik PM, Bomans P, Magusin PC, Nicolay K (2005) Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA 18(4):186–192
Kabalka G, Buonocore E, Hubner K, Moss T, Norley N, Huang L (1987) Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology 163(1):255–258
Kabalka GW, Davis MA, Moss TH, Buonocore E, Hubner K, Holmberg E, Maruyama K, Huang L (1991) Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver. Magn Reson Med 19(2):406–415
Trubetskoy VS, Cannillo JA, Milshtein A, Wolf GL, Torchilin VP (1995) Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn Reson Imaging 13(1):31–37
McDannold N, Fossheim SL, Rasmussen H, Martin H, Vykhodtseva N, Hynynen K (2004) Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology 230(3):743–752
Løkling KE, Fossheim SL, Skurtveit R, Bjørnerud A, Klaveness J (2001) pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. Magn Reson Imaging 19(5):731–738
Løkling KE, Skurtveit R, Fossheim SL, Smistad G, Henriksen I, Klaveness J (2003) pH-sensitive paramagnetic liposomes for MRI: assessment of stability in blood. Magn Reson Imaging 21(5):531–540
Fritz T, Unger E, Wilson-Sanders S, Ahkong QF, Tilcock C (1991) Detailed toxicity studies of liposomal gadolinium–DTPA. Invest Radiol 26(11):960–968
Unger EC, Fritz TA, Tilcock C, New TE (1991) Clearance of liposomal gadolinium: in vivo decomplexation. J Magn Reson Imaging 1(6):689–693
Trubetskoy VS, Torchilin VP (1994) New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes. J Lipid Res 4:961–980
Weissig V, Babich J, Torchilin VP (2000) Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids Surf B Biointerfaces 18:293–299
Erdogan S, Aruna R, Sawant R, Hurley J, Torchilin VP (2006) Gadolinium-loaded polychelating polymer-containing cancer cell-specific immunoliposomes. J Lipid Res 16:45–55
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284
Gupta H, Weissleder R (1996) Targeted contrast agents in MR imaging. Magn Reson Imaging Clin N Am 4:171–184
Morawski AM, Lanza GA, Wickline SA (2005) Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 16:89–92
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycoles effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237
Bertini I, Bianchini F, Calorini L et al (2004) Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn Reson Med 52:669–672
Iakoubov LZ, Torchilin VP (1998) Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosomespecific anticancer antibodies. Cancer Detect Prev 22:470–475
Chakilam AR, Pabba S, Mongayt D, Iakoubov LZ, Torchilin VP (2004) A single monoclonal antinuclear autoantibody with nucleosome-restricted specificity inhibits growth of diverse human tumors in nude mice. Cancer Ther 2:353–364
Erdogan S, Medarova ZO, Aruna R, Moore A, Torchilin VP (2008) Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. J Magn Reson Imaging 27:574–580
Acknowledgment
This study was supported by NIH Grant R01-EB002995 to Vladimir P. Torchilin.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Erdogan, S., Torchilin, V.P. (2010). Gadolinium-Loaded Polychelating Polymer-Containing Tumor-Targeted Liposomes. In: Weissig, V. (eds) Liposomes. Methods in Molecular Biology, vol 605. Humana Press. https://doi.org/10.1007/978-1-60327-360-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-60327-360-2_22
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-359-6
Online ISBN: 978-1-60327-360-2
eBook Packages: Springer Protocols